Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Recursion Pharmaceuticals
Biotech
Former FDA deputy joins AI biotech's board—Chutes & Ladders
Former FDA deputy joins AI biotech’s board. Summit flags new CCO. Struggling Cargo jettisons assets and execs.
Darren Incorvaia
,
Zoey Becker
Mar 21, 2025 8:30am
Altitude sources funding for biotechs concerned about NIH grants
Feb 19, 2025 1:00pm
Ovid pauses ph. 2 plans for ROCK2 inhibitor to mull rival's data
Nov 13, 2024 8:15am
Recursion's brain disease trial shows scant evidence of efficacy
Sep 3, 2024 10:30am
After a tough year, Exscientia folds into Recursion
Aug 8, 2024 8:54am
Recursion, Canaan, Metsera and more—Chutes & Ladders
Apr 19, 2024 8:30am
